BlobNotFoundThe specified blob does not exist. RequestId:d57d3c0e-401e-0067-51ff-118bce000000 Time:2019-05-24T07:11:37.3256781Z BlobNotFoundThe specified blob does not exist. RequestId:52fa6546-901e-0047-2aff-11e702000000 Time:2019-05-24T07:11:37.3304531Z BlobNotFoundThe specified blob does not exist. RequestId:f487dbd8-801e-0058-44ff-113c12000000 Time:2019-05-24T07:11:37.3288260Z
BlobNotFoundThe specified blob does not exist. RequestId:9de2cc05-401e-0001-75ff-113994000000 Time:2019-05-24T07:11:37.3292579Z
BlobNotFoundThe specified blob does not exist. RequestId:e93e622c-c01e-0054-35ff-11d2e3000000 Time:2019-05-24T07:11:37.3288732Z

2018年我国批准48个新药上市 抗癌药居多

健康 来源:央视网 2019年01月10日 09:44 A-A+ 二维码
扫一扫 手机阅读

原标题:

央视网消息:1月9日,国家药监局透露,2018年中国批准48个全新药品上市,以抗癌药、抗病毒药居多,大大丰富了癌症治疗的选择。

这48个新药中,38个来自进口,10个来自国产。涉及的适应症有多发性骨髓瘤、非小细胞肺癌、宫颈癌、卵巢癌、乳腺癌、黑色素瘤、肝癌、直肠癌、前列腺癌、白血病和淋巴瘤等。

另外,多个产品还与肿瘤适应症相关。比如,帕洛诺司琼获批用于治疗化疗引起的呕吐,拉布立海获批用于治疗儿童白血病和控制淋巴瘤患者的尿酸水平等。这些产品的上市将大大丰富我国癌症治疗选择,在很大程度上改变“以化疗为主流”的治疗现状。

艾滋病药物方面,国家药监局批准了本土原创新药艾博韦泰和进口鸡尾酒艾考恩丙替片、恩曲他滨丙酚替诺福韦片和达芦那韦考比司他片上市,使我国艾滋病用药的可及性得到大幅提高。

BlobNotFoundThe specified blob does not exist. RequestId:05eb6052-701e-0064-1cff-1188c9000000 Time:2019-05-24T07:11:37.3337925Z
BlobNotFoundThe specified blob does not exist. RequestId:cc99e8d1-501e-0111-52ff-114927000000 Time:2019-05-24T07:11:37.3360741Z 药监局 | 抗癌药
BlobNotFoundThe specified blob does not exist. RequestId:04c60af8-801e-009f-79ff-1140d3000000 Time:2019-05-24T07:11:37.3370515Z
我要纠错编辑:邹杨 责任编辑:张福伟
BlobNotFoundThe specified blob does not exist. RequestId:77343d8b-501e-00d9-21ff-119e45000000 Time:2019-05-24T07:11:37.3379641Z
BlobNotFoundThe specified blob does not exist. RequestId:db07b92d-d01e-00a5-40ff-110370000000 Time:2019-05-24T07:11:37.3384761Z
BlobNotFoundThe specified blob does not exist. RequestId:47ad8f2c-e01e-008f-1dff-117635000000 Time:2019-05-24T07:11:37.3402313Z BlobNotFoundThe specified blob does not exist. RequestId:8300fbec-901e-002a-27ff-114d2c000000 Time:2019-05-24T07:11:37.3383352Z BlobNotFoundThe specified blob does not exist. RequestId:17db9f50-301e-0123-3cff-1111f7000000 Time:2019-05-24T07:11:37.3391248Z
860010-1125010100
1 1 1